Endobronchial valve therapy in patients with homogeneous emphysema: results from the IMPACT study

Rationale: Endobronchial valves (EBVs) have been successfully used in patients with severe heterogeneous emphysema to improve lung physiology. Limited available data suggest that EBVs are also effective in homogeneous emphysema.Objectives: To evaluate the efficacy and safety of EBVs in patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Valipour, Arschang (VerfasserIn) , Herth, Felix (VerfasserIn) , Eberhardt, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 August 2016
In: American journal of respiratory and critical care medicine
Year: 2016, Jahrgang: 194, Heft: 9, Pages: 1073-1082
ISSN:1535-4970
DOI:10.1164/rccm.201607-1383OC
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1164/rccm.201607-1383OC
Verlag, kostenfrei, Volltext: http://www.atsjournals.org/doi/abs/10.1164/rccm.201607-1383OC
Volltext
Verfasserangaben:Arschang Valipour, Dirk-Jan Slebos, Felix Herth, Kaid Darwiche, Manfred Wagner, Joachim H. Ficker, Christoph Petermann, Ralf-Harto Hubner, Franz Stanzel, Ralf Eberhardt

MARC

LEADER 00000caa a2200000 c 4500
001 1562795074
003 DE-627
005 20230427122042.0
007 cr uuu---uuuuu
008 170828s2016 xx |||||o 00| ||eng c
024 7 |a 10.1164/rccm.201607-1383OC  |2 doi 
035 |a (DE-627)1562795074 
035 |a (DE-576)49279507X 
035 |a (DE-599)BSZ49279507X 
035 |a (OCoLC)1340978849 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Valipour, Arschang  |e VerfasserIn  |0 (DE-588)1138951897  |0 (DE-627)896569888  |0 (DE-576)492793344  |4 aut 
245 1 0 |a Endobronchial valve therapy in patients with homogeneous emphysema  |b results from the IMPACT study  |c Arschang Valipour, Dirk-Jan Slebos, Felix Herth, Kaid Darwiche, Manfred Wagner, Joachim H. Ficker, Christoph Petermann, Ralf-Harto Hubner, Franz Stanzel, Ralf Eberhardt 
264 1 |c 31 August 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2017 
520 |a Rationale: Endobronchial valves (EBVs) have been successfully used in patients with severe heterogeneous emphysema to improve lung physiology. Limited available data suggest that EBVs are also effective in homogeneous emphysema.Objectives: To evaluate the efficacy and safety of EBVs in patients with homogeneous emphysema with absence of collateral ventilation assessed with the Chartis system.Methods: Prospective, multicenter, 1:1 randomized controlled trial of EBV plus standard of care (SoC) or SoC alone. Primary outcome was the percentage change in FEV1 (liters) at 3 months relative to baseline in the EBV group versus the SoC group. Secondary outcomes included changes in FEV1, St. George’s Respiratory Questionnaire (SGRQ), 6-minute-walk distance (6MWD), and target lobe volume reduction.Measurements and Main Results: Ninety-three subjects (age, 63.7 ± 6.1 yr [mean ± SD]; FEV1, % predicted, 29.3 ± 6.5; residual volume, % predicted, 275.4 ± 59.4) were allocated to either the EBV group (n = 43) or the SoC group (n = 50). In the intention-to-treat population, at 3 months postprocedure, improvement in FEV1 from baseline was 13.7 ± 28.2% in the EBV group and −3.2 ± 13.0% in the SoC group (mean between-group difference, 17.0%; P = 0.0002). Other variables demonstrated statistically and clinically significant changes from baseline to 3 months (EBV vs. SoC, respectively: SGRQ, −8.63 ± 11.25 vs. 1.01 ± 9.36; and 6MWD, 22.63 ± 66.63 m vs. −17.34 ± 52.8 m). Target lobe volume reduction at 3 months was −1,195 ± 683 ml (P < 0.0001). Of the EBV subjects, 97.2% achieved volume reduction in the target lobe (P < 0.0001). Procedure-related pneumothoraces occurred in 11 subjects (25.6%). Five subjects required removal/replacement of one or more valves. One subject experienced two valve migration events requiring removal/replacement of valves.Conclusions: EBV in patients with homogeneous emphysema without collateral ventilation results in clinically meaningful benefits of improved lung function, exercise tolerance, and quality of life. 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Eberhardt, Ralf  |e VerfasserIn  |0 (DE-588)1055080406  |0 (DE-627)792649133  |0 (DE-576)176462120  |4 aut 
773 0 8 |i Enthalten in  |t American journal of respiratory and critical care medicine  |d New York, NY : American Thoracic Society, 1959  |g 194(2016), 9, Seite 1073-1082  |h Online-Ressource  |w (DE-627)26688492X  |w (DE-600)1468352-0  |w (DE-576)075961563  |x 1535-4970  |7 nnas  |a Endobronchial valve therapy in patients with homogeneous emphysema results from the IMPACT study 
773 1 8 |g volume:194  |g year:2016  |g number:9  |g pages:1073-1082  |g extent:10  |a Endobronchial valve therapy in patients with homogeneous emphysema results from the IMPACT study 
856 4 0 |u http://dx.doi.org/10.1164/rccm.201607-1383OC  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.atsjournals.org/doi/abs/10.1164/rccm.201607-1383OC  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170828 
993 |a Article 
994 |a 2016 
998 |g 1055080406  |a Eberhardt, Ralf  |m 1055080406:Eberhardt, Ralf  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PE1055080406  |e 950000PE1055080406  |e 950900PE1055080406  |e 50000PE1055080406  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 10  |y j 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
999 |a KXP-PPN1562795074  |e 2978655992 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"31 August 2016","dateIssuedKey":"2016"}],"person":[{"display":"Valipour, Arschang","role":"aut","given":"Arschang","family":"Valipour"},{"display":"Herth, Felix","family":"Herth","role":"aut","given":"Felix"},{"role":"aut","given":"Ralf","family":"Eberhardt","display":"Eberhardt, Ralf"}],"relHost":[{"pubHistory":["80.1959 -"],"titleAlt":[{"title":"AJRCCM online"},{"title":"AJRCCM"},{"title":"American review of respiratory diseases"}],"corporate":[{"display":"American Thoracic Society","role":"isb"}],"part":{"year":"2016","volume":"194","pages":"1073-1082","text":"194(2016), 9, Seite 1073-1082","extent":"10","issue":"9"},"id":{"zdb":["1468352-0"],"issn":["1535-4970"],"eki":["26688492X"]},"origin":[{"publisherPlace":"New York, NY ; New York, NY","dateIssuedKey":"1959","dateIssuedDisp":"1959-","publisher":"American Thoracic Society ; American Lung Association"}],"title":[{"subtitle":"AJRCCM ; an official journal of the American Thoracic Society, Medical Section of the Lung Association","title":"American journal of respiratory and critical care medicine","title_sort":"American journal of respiratory and critical care medicine"}],"note":["Gesehen am 17.01.2022"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"26688492X","physDesc":[{"extent":"Online-Ressource"}],"disp":"Endobronchial valve therapy in patients with homogeneous emphysema results from the IMPACT studyAmerican journal of respiratory and critical care medicine"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 28.08.2017"],"title":[{"subtitle":"results from the IMPACT study","title_sort":"Endobronchial valve therapy in patients with homogeneous emphysema","title":"Endobronchial valve therapy in patients with homogeneous emphysema"}],"physDesc":[{"extent":"10 S."}],"recId":"1562795074","name":{"displayForm":["Arschang Valipour, Dirk-Jan Slebos, Felix Herth, Kaid Darwiche, Manfred Wagner, Joachim H. Ficker, Christoph Petermann, Ralf-Harto Hubner, Franz Stanzel, Ralf Eberhardt"]},"id":{"eki":["1562795074"],"doi":["10.1164/rccm.201607-1383OC"]}} 
SRT |a VALIPOURARENDOBRONCH3120